Results 11 to 20 of about 13,736 (119)

Data deluge from remote monitoring of cardiac implantable electronic devices and importance of clinical stratification

Heart Rhythm O2, 2023
Background: Remote monitoring (RM) has been accepted as a standard of care for follow-up of patients with cardiac implantable electronic devices (CIEDs). However, the resulting data deluge poses major challenge to device clinics.
Danish Bawa, MD, Rajesh Kabra, MD, FHRS, Adnan Ahmed, MD, Shanti Bansal, MD, FHRS, Douglas Darden, MD, FHRS, Naga Venkata K. Pothineni, MD, FHRS, Rakesh Gopinathannair, MD, FHRS, Dhanunjaya Lakkireddy, MD, FHRS   +7 more
doaj   +1 more source

Comparison of Anxiety and Depression Symptoms in Individuals According to their Sex, Type of Cardiac Device, and Diagnosis of Chagas Disease

Brazilian Journal of Cardiovascular Surgery, 2022
Introduction: Implantable cardiac pacemakers or cardioverter defibrillators are alternatives for the treatment of arrhythmias, however, their use has caused changes in the emotional state of patients.
Carina Aparecida Marosti Dessotte, Elisa Maia de Oliveira Grotti, Isabelle Brigliadori Ignácio, Paolla Algarte Fernandes, Suellen Rodrigues de Oliveira Maier, Lidia Aparecida Rossi, Rosana Aparecida Spadoti Dantas   +6 more
doaj   +1 more source

Inappropriate ICD Shock as a Result of TASER Discharge

JACC: Case Reports, 2020
Conducted energy weapon (commonly known as TASER) discharge in patients with implantable cardioverter-defibrillators is known to cause electromagnetic interference and inappropriate ventricular fibrillation sensing without delivery of implantable ...
Chirag R. Barbhaiya, MD, Craig Moskowitz, MD, Harish Duraiswami, CCDS, Lior Jankelson, MD, PhD, Robert J. Knotts, MD, Scott Bernstein, MD, David Park, MD, PhD, Douglas Holmes, MD, Anthony Aizer, MD, MS, Larry A. Chinitz, MD   +9 more
doaj   +1 more source

Incidence and Costs Related to Lead Damage Occurring Within the First Year After a Cardiac Implantable Electronic Device Replacement Procedure

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundInadvertent damage to leads for transvenous pacemakers, implantable cardioverter‐defibrillators, and cardiac resynchronization therapy defibrillators is an important complication associated with generator‐replacement procedures.
Christine I. Nichols, Joshua G. Vose, Suneet Mittal   +2 more
doaj   +1 more source

PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015)

Вестник анестезиологии и реаниматологии, 2018
The frequency of sudden cardiac death remains still high, globally every year 3 mln. people suddenly die. During last thirty years it has been possible to prevent sudden cardiac death by using implantable cardioverter-defibrillators.
N. V. Melnik
doaj   +1 more source

Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs

Sensors, 2021
The management of heart failure remains challenging despite evidence-based medical and pharmacological advances, especially in the ambulatory setting. There is an urgent need to develop strategies to reduce hospitalizations and readmission rates due to ...
Dominic A. M. J. Theuns, Sumant P. Radhoe, Jasper J. Brugts   +2 more
doaj   +1 more source

Inevitable high-dose irradiation to lead of implantable cardioverter defibrillator in small cell lung cancer: a case report

Journal of Medical Case Reports, 2019
Background Radiotherapy has been shown to cause malfunction of implantable cardioverter-defibrillators, and there are few studies of implantable cardioverter-defibrillators and radiotherapy.
Jeong Won Lee, Ki Ho Seol
doaj   +1 more source

Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
Background Whether outcomes differ between sexes following treatment with pacemakers (PM), implantable cardioverter defibrillators, and cardiac resynchronization therapy (CRT) devices is unclear.
Niraj Varma, Suneet Mittal, Julie B. Prillinger, Jeff Snell, Nirav Dalal, Jonathan P. Piccini   +5 more
doaj   +1 more source

Ventricular Arrhythmias Among Patients With Advanced Heart Failure: A Population‐Based Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background The epidemiology of ventricular arrhythmias (VAs) in patients with advanced heart failure (HF) is not well defined. Methods and Results Residents of Olmsted County, Minnesota, with advanced HF from 2007 to 2017 were identified using the 2018 ...
Nicholas Y. Tan, Veronique L. Roger, Jill M. Killian, Yong‐Mei Cha, Peter A. Noseworthy, Shannon M. Dunlay   +5 more
doaj   +1 more source

Should all patients receive dual chamber pacing ICDs? The rationale for the DAVID trial

Current Controlled Trials in Cardiovascular Medicine, 2001
All of the prospective multicenter trials that support the use of implantable defibrillators have used single chamber pacemakers/implantable cardiovertor defibrillators (ICDs).
Wilkoff Bruce L
doaj   +1 more source